FDA Approves Zyprexa IM; Milestone In Lilly GMP Turnaround

Lilly's Zyprexa IM has cleared FDA three years after a pre-approval inspection for the intramuscular antipsychotic triggered a period of Good Manufacturing Practices compliance issues for the company